Scarica l'app Stockscreener
11.95
1.08%
-0.13
Dopo l'orario di chiusura:
11.95
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCM Giù?
Forum
Previsione
R1 RCM Inc. Borsa (RCM) Ultime notizie
Compared to Estimates, R1 RCM INC (RCM) Q1 Earnings: A Look at Key Metrics
Zacks Investment Research
R1 RCM to Present at the 2024 Bank of America Securities Health Care Conference
GlobeNewswire Inc.
The Latest Analyst Ratings For R1 RCM
Benzinga
R1 RCM to Release First Quarter 2024 Results on May 8, 2024
GlobeNewswire Inc.
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report
GlobeNewswire Inc.
Analyst Scoreboard: 12 Ratings For R1 RCM
Benzinga
New Strong Sell Stocks for March 12th
Zacks Investment Research
Alphabet, Dover And 2 Other Stocks Insiders Are Selling
Benzinga
Assessing R1 RCM: Insights From 10 Financial Analysts
Benzinga
Compared to Estimates, R1 RCM Inc. (RCM) Q4 Earnings: A Look at Key Metrics
Zacks Investment Research
R1 RCM Inc. (RCM) Reports Break-Even Earnings for Q4
Zacks Investment Research
R1 RCM Reports Fourth Quarter and Full Year 2023 Results
GlobeNewswire Inc.
US Stocks Pause, Alphabet Falls On Gemini Woes, Tesla, Bitcoin Rally: What's Driving Markets Monday?
Benzinga
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Should You Buy R1 RCM (RCM) Ahead of Earnings?
Zacks Investment Research
SPX Technologies (SPXC) Q4 Earnings Meet Estimates
Zacks Investment Research
Ahead of R1 RCM Inc. (RCM) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Zacks Investment Research
R1 RCM Inc. (RCM) Reports Next Week: Wall Street Expects Earnings Growth
Zacks Investment Research
R1 RCM to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
TIXT vs. RCM: Which Stock Is the Better Value Option?
Zacks Investment Research
R1 RCM Completes Acquisition of Acclara, Providence’s Modular Services Business
GlobeNewswire Inc.
What 10 Analyst Ratings Have To Say About R1 RCM
Benzinga
20 midcap stocks with 2024 upside ranging up to 62%, according to analysts
MarketWatch
20 midcap stocks with 2024 upside ranging up to 62%, according to analysts
MarketWatch
R1 RCM to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Wall Street Revels In Gains As AI, Tech Titans Surge; Dollar Plunges Against Yen: What's Driving Markets Thursday?
Benzinga
R1 RCM to Acquire Acclara
GlobeNewswire Inc.
What 6 Analyst Ratings Have To Say About R1 RCM
Benzinga
R1 Completes Restatement of Previously Issued Financial Statements
GlobeNewswire Inc.
R1 RCM Receives Notice of Filing Delinquency from Nasdaq
GlobeNewswire Inc.
1.63%
0.04%
Capitalizzazione:
|
Volume (24 ore):